TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019.

Myron J Levin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.